Only a handful of places left for our September 2026 cohort. Applications close soonApply now →

MSTA
Your future
starts here.

Melanogenesis

Also known as: melanin production, melanin synthesis, melanogenesis, pigment production

Melanogenesis is the production of melanin within melanocyte melanosomes and its subsequent distribution to keratinocytes. It is regulated by genetic, ultraviolet, visible-light, hormonal and inflammatory signalling; excessive or persistent activation contributes to hyperpigmentation disorders.

Evidence status

Moderate

Core melanin synthesis and UV-response pathways are well established. The dominant transfer mechanism, the contribution of individual signals in disease, and translation from laboratory targets to clinical outcomes remain less certain.

Definition#

Melanogenesis is the production of melanin by melanocytes within melanosomes. In normal epidermis, melanin is then transferred to keratinocytes and arranged around their nuclei, contributing to visible skin colour and partial protection from UV damage.[1, 2]

The word is commonly used for synthesis alone. Clinically, it is more useful to think about the full pigment journey: signal → synthesis → packaging → transfer → distribution → clearance.

The epidermal melanin unit#

A melanocyte sits in the basal epidermis and communicates with multiple keratinocytes through branching dendrites. Together they form an epidermal melanin unit. The melanocyte produces pigment-containing melanosomes; keratinocytes receive and distribute that material as they move upwards through the epidermis.[1, 2]

This relationship explains why pigment is not solely a “melanocyte problem”. Keratinocytes release signals after UV exposure or inflammation. Fibroblasts, immune mediators, vascular change and the extracellular environment can also influence pigment behaviour. That wider network becomes especially important in melasma and PIH.

How melanin is made#

Melanin synthesis begins with the amino acid tyrosine. The enzyme tyrosinase catalyses the early conversion of tyrosine towards DOPA and dopaquinone. From this branch point, cellular conditions influence the formation of two broad pigment families:

  • Eumelanin: brown-to-black pigment with greater photoprotective capacity.
  • Pheomelanin: yellow-to-red pigment with different chemical and photobiological properties.

The transcription factor MITF regulates several melanocyte genes, including tyrosinase and related enzymes. Melanocortin-1 receptor signalling, often activated through α-MSH, can shift melanocyte activity and favour eumelanin production.[1, 2, 5]

This pathway makes tyrosinase a logical treatment target, but tyrosinase is not a master switch for the whole visible result. A compound can inhibit an enzyme in a laboratory assay without reaching the right site in human skin, remaining stable in a formulation, being tolerated long enough, or producing a clinically meaningful change.

From melanocyte to keratinocyte#

Mature melanosomes move along melanocyte dendrites and their pigment reaches keratinocytes. What sounds like a settled handover is still an active research question. Proposed routes include shed vesicles containing melanosomes, cytophagocytosis of melanocyte dendrites, exocytosis of melanosome contents, and transfer through tunnelling nanotubes. Several models have experimental support; the dominant route in living human epidermis and the subsequent processing inside keratinocytes remain debated.[5]

That uncertainty does not undermine the clinical fact that transfer occurs. It changes how confidently we should describe the microscopic handover — and why “blocks pigment transfer” should be treated as a mechanism claim unless a finished product has clinical outcome data.

What regulates melanogenesis?#

Ultraviolet radiation

After UV exposure, DNA-stress signalling in keratinocytes can activate p53, increase POMC expression and release melanocortin signals including α-MSH. These signals bind melanocyte receptors and increase pigment activity, contributing to tanning.[2, 3]

Note what that evidence is. The causal demonstration of the p53 step rests on cellular assays and p53-knockout mice. It is mechanistic and animal evidence for a pathway, not a human intervention result — and this page described it without the model until August 2026.

The response is protective but incomplete. Melanin absorbs and disperses some UV energy and helps shield nuclear DNA, yet no natural phototype is immune to UV injury.[9]

Visible light

Visible light is not biologically neutral for all skin. In a controlled study of 20 people with phototypes IV–VI, visible light produced pigmentation that was darker and more sustained than that produced by the UVA1 exposure studied alongside it.[4] This is relevant to disorders such as melasma, but the population boundary matters: the study does not show an equal response in every phototype or under every everyday exposure.

Inflammation

Inflammation changes the signalling environment around melanocytes. Prostaglandins, leukotrienes, cytokines and growth factors can alter melanocyte activity, dendricity and transfer. Importantly, different mediators can stimulate or inhibit melanogenesis.[6]

Clinically, inflammation is still a central pigment risk because skin injury can produce a persistent visible result. The nuance is that the biology is a network, not one universal “inflammation makes melanin” switch.

Hormonal signalling

Hormonal associations are particularly visible in melasma and pregnancy-associated change. Experimental research shows that oestrogen and progesterone can act on human melanocytes through nonclassical membrane receptors and produce different pigment effects.[7]i

Again, the model matters. That work used cultured primary human melanocytes— from discarded foreskin and surgical tissue — and engineered organotypic skin, treated over about four days. Human cells, and not a person. It is biological support for hormonal influence on pigment; it does not show that an individual’s hormone levels predict, cause or treat a patch of pigmentation.

Temperature and heat

Heat is frequently presented online as a proven pigmentation trigger. The evidence is considerably less settled than the confidence of that claim. The cell-culture study usually cited tested cooling, not heating: lowering the culture temperature to 31°C reduced melanin synthesis and tyrosinase activity in a duration-dependent way.[8] It did not establish that normal facial warmth, a warm room or any specific real-world temperature independently causes melasma or PIH.

Heat may accompany UV exposure, vascular change, inflammation or an energy-based procedure, but those overlapping variables make simple causal statements difficult. For now, everyday heat belongs in the uncertainty discussion, not beside UV as an equally proven driver.

Why skin colours differ#

Human skin colours overlap across ancestry and do not divide into neat biological groups. The density of epidermal melanocytes alone does not explain the visible range. Differences in melanocyte activity, melanosome size and organisation, the mixture of melanin types, distribution within keratinocytes and degradation all contribute.[1, 2, 10]

UV responses also vary. Comparative human research has found differences in tanning biology and melanosome organisation among studied racial and ethnic groups, while also showing that population labels are an imperfect proxy for individual biology. This is why ethnicity and Fitzpatrick phototype should never be treated as interchangeable measurements.

In professional practice#

The pathway suggests four broad ways a pigmentation plan may act:

  1. Reduce new signalling— particularly UV and relevant visible-light exposure, while controlling an inflammatory trigger.
  2. Modulate synthesis— through ingredients or medicines with evidence for specific pigment conditions.
  3. Influence transfer or epidermal turnover— where clinical evidence and tolerance support the approach.
  4. Avoid adding inflammation— because an over-aggressive “corrective” plan can create the stimulus it is trying to remove.

The order matters. If acne, dermatitis, friction, picking or procedure-related inflammation continues, a pigment-directed treatment is working against an active source. The practical lesson from melanogenesis is not to stack every plausible inhibitor; it is to identify which signals are still present and choose an evidence-led, tolerable plan for the actual condition.

For a worked example of cause-first thinking in a body site where hair shadow, friction, ingrown hairs, dermatitis and medical differentials can look similar, see MSTA’s underarm hyperpigmentation guide.

Reading ingredient and treatment claims#

Pigment products are often grouped by proposed mechanism:

  • tyrosinase or melanogenesis modulation;
  • antioxidant or anti-inflammatory action;
  • melanosome-transfer modulation;
  • increased epidermal turnover;
  • UV and visible-light photoprotection.

These categories are helpful for formulation literacy, not sufficient for ranking products. To move from a pathway claim to a practice claim, ask:

  • Was the finished formulation studied, or only an isolated ingredient?
  • Was the research in cells, reconstructed skin or people?
  • Was the condition PIH, melasma, a solar lentigo or undefined “uneven tone”?
  • Were baseline skin colour and phototype reported?
  • Did the study measure a meaningful clinical outcome and tolerability?
  • Was improvement sustained after treatment stopped?

The same discipline applies to peels, light and laser. Removing visible pigment is different from switching off the signals that created it. In melasma especially, a quick initial change may coexist with relapse or treatment-induced dyschromia.

Contraindications and cautions#

Melanogenesis is physiology, not a diagnosis. Aesthetic pigment management should pause when the diagnosis is uncertain; a lesion is new, changing, irregular, raised, bleeding, painful or itchy; pigment appears without an intelligible trigger; or the presentation suggests a medical or medication-related cause.

Also avoid inferring suitability from mechanism alone. Pregnancy, prescription medicines, active inflammation, barrier impairment, phototype, prior PIH and the practitioner’s scope can all alter what is appropriate even when an ingredient has a plausible pigment target.

What the evidence currently supports#

The central architecture of melanin synthesis inside melanosomes, melanocyte–keratinocyte communication and UV-responsive signalling is well supported. Human studies support visible-light-induced pigmentation in melanocompetent skin and meaningful differences in pigment organisation and UV response.

Inflammatory and sex-steroid pathways have credible mechanistic evidence. Their relative contribution in a particular person or disorder is much harder to quantify. The evidence therefore supports a multi-signal model, not a universal explanation for every dark mark.

What remains uncertain#

  • Which melanin-transfer route dominates in living human epidermis.
  • How individual inflammatory mediators combine in a real episode of PIH.
  • How experimental sex-steroid effects translate into the course of an individual’s melasma.
  • Whether everyday non-procedural heat is an independent, clinically important pigment trigger and, if so, at what exposure.
  • How well many ingredient mechanism claims translate from cells to a finished formulation and durable human outcomes.
  • Whether visible-light results in phototypes IV–VI can be generalised across all skin.

Common misconceptions#

“Darker skin has more melanocytes.”

Not as a complete explanation. Visible differences depend heavily on melanocyte activity, melanosome properties, distribution and persistence.[1, 2, 10]

“Tyrosinase is the only pigment target.”

It is a central enzyme, but visible pigment also depends on signalling, transfer, distribution, turnover and the location of pigment.[1, 2, 5]

“Inflammation always increases melanogenesis.”

Clinically it is an important PIH trigger, but individual inflammatory mediators can stimulate or inhibit melanogenesis.[6]

“Visible light from every screen causes melasma.”

Controlled visible light can induce pigmentation in melanocompetent skin, but this does not make the intensity and dose from personal electronic screens equivalent to sunlight.[4]

“If a product targets the pathway, it must work.”

A mechanistic target is the beginning of an evidence chain, not the clinical endpoint.

Frequently asked questions#

Is melanin harmful?

No. Melanin is normal and contributes to skin, hair and eye colour as well as partial UV protection. Problems arise when pigment is absent, unevenly distributed or persistently increased in a way that reflects a disorder or follows injury.[9]

What is the difference between melanin and melanogenesis?

Melanin is the pigment. Melanogenesis is the process by which melanocytes produce it.

Is tanning the same as hyperpigmentation?

Both involve pigment responses, but tanning is a broader UV-induced adaptation. PIH and melasma have distinct triggers, distributions and clinical behaviour. A tan does not prove that a focal dark patch is benign.

Does exfoliation stop melanogenesis?

Exfoliation may remove pigmented keratinocytes or alter turnover. It does not necessarily remove the signal driving new pigment, and excessive exfoliation can create inflammation.

Why can pigmentation return after it lightens?

Visible clearance and biological control are not the same. UV, visible light, hormonal influence or ongoing inflammation may reactivate the pathway, while dermal pigment clears slowly.

References#

Each source is graded by evidence tier. Tier 4 material (manufacturer documents, expert consensus, practitioner experience) is useful for protocol and context, and is never presented as equivalent to independent clinical evidence.

  1. Costin GE, Hearing VJ. Human skin pigmentation: melanocytes modulate skin color in response to stress. FASEB Journal. 2007;21(4):976–994. doi:10.1096/fj.06-6649rev.Tier 4Supports: Core melanocyte, melanosome, melanin-synthesis and pigment-distribution biology.
  2. Yamaguchi Y, Hearing VJ. Physiological factors that regulate skin pigmentation. BioFactors. 2009;35(2):193–199. doi:10.1002/biof.29.Tier 4Supports: Physiological regulation of pigmentation and melanocyte–keratinocyte signalling.
  3. Cui R, Widlund HR, Feige E, et al. Central role of p53 in the suntan response and pathologic hyperpigmentation. Cell. 2007;128(5):853–864. doi:10.1016/j.cell.2006.12.045.Animal studyTier 3Supports: The UV–keratinocyte p53–POMC/α-MSH pathway in tanning and hyperpigmentation. TYPED ANIMAL because the causal demonstration rests on p53-knockout MICE alongside cellular assays. It is mechanistic and animal evidence for the pathway, not a human intervention result.
  4. Mahmoud BH, Ruvolo E, Hexsel CL, et al. Impact of long-wavelength UVA and visible light on melanocompetent skin. Journal of Investigative Dermatology. 2010;130(8):2092–2097. doi:10.1038/jid.2010.95.Tier 3Supports: In 20 volunteers of skin types IV–VI, visible light produced pigmentation that was darker and more sustained than UVA1-induced pigmentation.Funding / interest: Company employment is relevant provenance even where the article's own conflict line says none: coauthors Eduardo Ruvolo, Yang Liu and Nikiforos Kollias were affiliated with Johnson & Johnson. We located no separate study-funding statement in the accessible record — which is not the same as the work being independent.
  5. Benito-Martínez S, Salavessa L, Raposo G, Marks MS, Delevoye C. Melanin Transfer and Fate within Keratinocytes in Human Skin Pigmentation. Integrative and Comparative Biology. 2021;61(4):1546–1555. doi:10.1093/icb/icab094.Tier 4Supports: Four competing models of melanin transfer (shed vesicles, cytophagocytosis, exocytosis, tunnelling nanotubes); the mechanism and the fate of melanin inside keratinocytes are described as debated and poorly understood.
  6. Fu C, Chen J, Lu J, et al. Roles of inflammation factors in melanogenesis. Molecular Medicine Reports. 2020;21(3):1421–1430. doi:10.3892/mmr.2020.10950.Tier 4Supports: Inflammatory mediators can stimulate or inhibit melanogenesis depending on signal and context.
  7. Natale CA, Duperret EK, Zhang J, et al. Sex steroids regulate skin pigmentation through nonclassical membrane-bound receptors. eLife. 2016;5:e15104. doi:10.7554/eLife.15104.In vitroTier 3Supports: Cultured PRIMARY HUMAN MELANOCYTES obtained from discarded foreskin and surgical tissue, plus engineered organotypic skin grafts, treated over about four days with oestradiol and progesterone, producing reciprocal pigment effects through non-classical membrane-bound receptors. TYPED IN-VITRO: this is culture and engineered tissue, not people. It does not show that an individual's hormone levels predict, cause or treat a pigmentary disorder.
  8. Kim DS, Park SH, Kwon SB, et al. Temperature regulates melanin synthesis in melanocytes. Archives of Pharmacal Research. 2003;26(10):840–845. doi:10.1007/BF02980030.In vitroTier 3Supports: Cell culture only. LOWERING culture temperature to 31°C reduced tyrosinase activity and melanin synthesis in a duration-dependent way. The study did not test raised temperature and does not establish a clinical everyday-heat threshold.
  9. Brenner M, Hearing VJ. The protective role of melanin against UV damage in human skin. Photochemistry and Photobiology. 2008;84(3):539–549. doi:10.1111/j.1751-1097.2007.00226.x.Tier 4Supports: The mechanisms and limits of endogenous melanin photoprotection.
  10. Tadokoro T, Yamaguchi Y, Batzer J, et al. Mechanisms of skin tanning in different racial/ethnic groups in response to ultraviolet radiation. Journal of Investigative Dermatology. 2005;124(6):1326–1332. doi:10.1111/j.0022-202X.2005.23760.x.Tier 3Supports: Differences in UV-induced pigment response and melanosome organisation across the studied groups.Funding / interest: Coauthors Jan Batzer and Rainer Wolber were affiliated with Beiersdorf R&D / Beiersdorf Skin Research. We located no separate study-funding statement in the accessible record — which is not the same as the work being independent.

Continue learning with MSTA#

Skinipedia is written by the educators at MSTA, the medic-led skincare training academy in Liverpool.